Clinical Trial Update: Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation [Phase 3]

View source ↗

Summary

A Phase 3 placebo-controlled trial evaluated the safety and efficacy of a controlled-release formulation of galantamine for Alzheimer’s disease, with completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Alzheimer Disease, Dementia | Phase 3 | Status: COMPLETED